Clinical Trials Directory

Trials / Completed

CompletedNCT06136923

An Exploratory Study to Evaluate Attention Biases in Adults With Multiple Sclerosis, Breast Cancer, and Lung Cancer

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
194 (actual)
Sponsor
Click Therapeutics, Inc. · Industry
Sex
All
Age
22 Years – 65 Years
Healthy volunteers
Not accepted

Summary

CT-100 is a platform that provides interactive, software based therapeutic components that may be used as part of a treatment in future software-based prescription digital therapeutics. One class of CT-100 components are Digital Neuro-activation and Modulation (DiNaMo) components. DiNaMo components target key neural systems (including but not limited to systems related to sensory-, perceptual-, affective-, pain-, attention-, cognitive control, social- and self-processing) to optimally improve a participant's health.

Detailed description

CT-100 is a platform that provides interactive, software based therapeutic components that may be used as part of a treatment in future software-based prescription digital therapeutics. One class of CT-100 components are Digital Neuro-activation and Modulation (DiNaMo) components. DiNaMo components target key neural systems (including but not limited to systems related to sensory-, perceptual-, affective-, pain-, attention-, cognitive control, social- and self-processing) to optimally improve a participant's health. Targeted cognitive training is used to reduce symptoms relevant to multiple sclerosis (MS) and cancer. Biases to direct attention towards or away from certain stimuli can exacerbate a variety of symptoms in many different indications. For example, in chronic pain conditions, patients are more attentive to pain-related stimuli, which can lead to hypersensitization. Similarly, hypersensitivity to threat-related stimuli can exacerbate anxiety. In this treatment, users are trained to re-orient attention away from negative stimuli, such as pain- or threat-related stimuli.

Conditions

Interventions

TypeNameDescription
DEVICECT-100-D-004-AAttention Biases App CT-100-D-004-A Digital Neuro-activation and Modulation (DiNaMo) component uses implicit training to redirect and strengthen attention processes. This intervention can help improve cognitive capabilities as well as redirect attentional biases to make participants less sensitive to distressing stimuli.
DEVICECT-100-D-004-BAttention Biases App CT-100-D-004-B Digital Neuro-activation and Modulation (DiNaMo) component uses implicit training to redirect and strengthen attention processes. This intervention can help improve cognitive capabilities as well as redirect attentional biases to make participants less sensitive to distressing stimuli.

Timeline

Start date
2023-10-19
Primary completion
2024-04-18
Completion
2024-05-06
First posted
2023-11-18
Last updated
2024-05-13

Locations

1 site across 1 country: United States

Source: ClinicalTrials.gov record NCT06136923. Inclusion in this directory is not an endorsement.